Table 1.
Patient No.† |
Days from Illness Onset to Specimen Collection |
Specimen Type |
Reciprocal IgM and IgG Titer, CDC Assay | Reciprocal IgG Titer, Mayo Clinic Assay | ||||||
---|---|---|---|---|---|---|---|---|---|---|
New Ehrlichia Species |
E. chaffeensis | A. phagocytophilum | E. chaffeensis | A. phagocytophilum | ||||||
IgM | IgG | IgM | IgG | IgM | IgG | |||||
1 | 198 | Plasma | 256 | 128 | 256 | <16 | <16 | <16 | NA | NA |
2 | 2 | Serum | NA | NA | NA | <32 | NA | <32 | <64 | <64 |
2 | 15 | Serum | 512 | 256 | 256 | 64 | <16 | <16 | <64 | <64 |
2 | 188 | Plasma | 16 | 64 | <16 | 32 | <16 | <16 | NA | NA |
4 | 7 | Serum | NA | NA | NA | NA | NA | NA | 256 | <64 |
4 | 46 | Serum | NA | NA | NA | NA | NA | NA | 1024 | <64 |
4 | 76 | Plasma | 32 | 2048 | <16 | 2048 | <16 | <16 | NA | NA |
Antibody titers were assessed with the use of a noncommercial indirect immunofluorescence assay at the Centers for Disease Control and Prevention and with the use of a commercial indirect immunofluorescence assay (testing for IgG antibody but not IgM antibody) at the Mayo Clinic. NA denotes not available.
Specimens from Patient 3 were not available for testing.